SGHT Q4 2021 Earnings — Sight Sciences, Inc. Revenue & Financial Results | Market Cap Arena

SGHTSight Sciences, Inc.

$224M

Q4 2021 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$15M+63.3% YoY

Gross Profit

$13M86.8% margin

Operating Income

-$15M-100.2% margin

Net Income

-$16M-108.5% margin

EPS (Diluted)

$-0.34

QoQ Revenue Growth

+12.1%

Cash Flow

Operating Cash Flow

-$11M

Free Cash Flow

-$11M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$280M

Total Liabilities

$48M

Stockholders' Equity

$232M

Cash & Equivalents

$261M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$15M	$9M	+63.3%
Gross Profit	$13M	$7M	+92.6%
Operating Income	-$15M	-$8M	-74.5%
Net Income	-$16M	-$9M	-75.0%

Revenue Segments

Surgical Glaucoma

$14M95%

Dry Eye

$762,0005%